• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用δ-8-四氢大麻酚与州级大麻政策有关联吗?来自美国不同司法管辖区的内容分析。

Is Delta-8-THC use associated with state-level cannabis policies? A content analysis from different jurisdictions in the United States.

作者信息

Dawson Danielle, York Ashley, Su Fang-Yi, Hall Wayne, Lim Carmen, Stjepanović Daniel

机构信息

National Centre for Youth Substance Use Research, The University of Queensland, St Lucia QLD 4072, Australia.

School of Psychology, The University of Queensland, St Lucia QLD 4072, Australia.

出版信息

J Stud Alcohol Drugs. 2024 Oct 31. doi: 10.15288/jsad.24-00297.

DOI:10.15288/jsad.24-00297
PMID:39480686
Abstract

BACKGROUND

The United States has seen a rapid increase in the use of Δ-8-tetrahydrocannabinol (Δ-THC), a psychoactive compound similar to Δ-9-tetrahydrocannabinol (Δ-THC). This study aimed to explore themes in Δ-THC related tweets from U.S. jurisdictions with varying cannabis regulations from 2020 to 2022.

METHODS

Tweets mentioning Δ-THC were collected using search terms: D8, Delta-8, and Delta8 THC. The tweets were date-restricted from January 21, 2020, to May 31, 2022, resulting in 139,843 tweets. The final dataset included 61,800 U.S. tweets with complete location data. A subset of 1,000 tweets ( = 250 for each legal jurisdiction) was selected for content analysis.

RESULTS

Three main themes related to Δ-THC emerged across all jurisdictions: 'Sales and Advertising', 'Policy', and 'Personal Use'. In states where cannabis was legal for adult use, sales-themed tweets were most prevalent, promoting product sales and discounts. 'Policy' tweets were more common in medical CBD-only (34.5%) and fully illegal (24.8%) jurisdictions than in those with legalized medical (20.4%) and adult use (20.2%). Tweets about personal use appeared at similar rates in fully illegal (27.7%), medical (25.0%), medical CBD-only (24.5%), and fully legal jurisdictions (22.8%). Reports of adverse effects were frequent in tweets from fully illegal (28.9%), fully legal (27.7%), and medical (27.7%) jurisdictions, with the lowest frequency in medicinal CBD-only (15.6%) jurisdictions.

CONCLUSION

The current study on the public discourse on Twitter indicates that discussions about the use and marketing of Δ-THC are present in all U.S. jurisdictions, not just those without legal recreational cannabis markets.

摘要

背景

美国使用Δ-8-四氢大麻酚(Δ-THC)的情况迅速增加,Δ-8-四氢大麻酚是一种与Δ-9-四氢大麻酚(Δ-THC)类似的精神活性化合物。本研究旨在探讨2020年至2022年美国不同大麻法规管辖区与Δ-THC相关推文的主题。

方法

使用搜索词“D8”“Delta-8”和“Delta8 THC”收集提及Δ-THC的推文。推文的日期限制为2020年1月21日至2022年5月31日,共得到139,843条推文。最终数据集包括61,800条有完整位置数据的美国推文。选取了1000条推文的子集(每个法律管辖区250条)进行内容分析。

结果

所有管辖区出现了与Δ-THC相关的三个主要主题:“销售与广告”“政策”和“个人使用”。在大麻对成年人合法的州,以销售为主题的推文最为普遍,宣传产品销售和折扣。“政策”推文在仅医疗用大麻二酚合法(34.5%)和完全非法(24.8%)的管辖区比在医疗用大麻合法(20.4%)和成年人使用合法(20.2%)的管辖区更常见。关于个人使用的推文在完全非法(27.7%)、医疗用大麻合法(25.0%)、仅医疗用大麻二酚合法(24.5%)和完全合法(22.8%)的管辖区出现的比例相似。在完全非法(28.9%)、完全合法(27.7%)和医疗用大麻合法(27.7%)的管辖区的推文中,不良反应报告频繁,在仅医疗用大麻二酚合法(15.6%)的管辖区频率最低。

结论

目前关于推特上公众话语的研究表明,关于Δ-THC使用和营销的讨论在美国所有管辖区都存在,而不仅仅是那些没有合法休闲大麻市场的管辖区。

相似文献

1
Is Delta-8-THC use associated with state-level cannabis policies? A content analysis from different jurisdictions in the United States.使用δ-8-四氢大麻酚与州级大麻政策有关联吗?来自美国不同司法管辖区的内容分析。
J Stud Alcohol Drugs. 2024 Oct 31. doi: 10.15288/jsad.24-00297.
2
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
3
Psychosocial interventions for cannabis use disorder.针对大麻使用障碍的心理社会干预措施。
Cochrane Database Syst Rev. 2016 May 5;2016(5):CD005336. doi: 10.1002/14651858.CD005336.pub4.
4
Cannabinoid content on product labels influences cannabis health perceptions.产品标签上的大麻素含量会影响对大麻健康的认知。
Ann Behav Med. 2025 Jan 4;59(1). doi: 10.1093/abm/kaaf046.
5
Getting "The whole picture": A review of international research on the outcomes of regulated cannabis supply.全面了解:关于合法大麻供应结果的国际研究综述
Int J Drug Policy. 2025 Aug;142:104796. doi: 10.1016/j.drugpo.2025.104796. Epub 2025 May 19.
6
Cannabis-based medicines for chronic neuropathic pain in adults.用于成人慢性神经性疼痛的大麻类药物。
Cochrane Database Syst Rev. 2018 Mar 7;3(3):CD012182. doi: 10.1002/14651858.CD012182.pub2.
7
Cannabinoids for the treatment of dementia.大麻素治疗痴呆。
Cochrane Database Syst Rev. 2021 Sep 17;9(9):CD012820. doi: 10.1002/14651858.CD012820.pub2.
8
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.大麻和大麻素治疗多发性硬化症患者的症状。
Cochrane Database Syst Rev. 2022 May 5;5(5):CD013444. doi: 10.1002/14651858.CD013444.pub2.
9
Factors Associated with Medical Cannabis Use After Certification: A Three-Month Longitudinal Study.与医疗大麻使用相关的因素:一项为期三个月的纵向研究。
Cannabis Cannabinoid Res. 2024 Jun;9(3):e859-e869. doi: 10.1089/can.2022.0248. Epub 2023 Mar 24.
10
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.